Download PDF
Thromb Haemost 1968; 19(01/02): 107-116
DOI: 10.1055/s-0038-1651187
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Observations on the Lysis of Artificial Thrombi by Urokinase[*]

C. M Ogston
1   Department of Medicine, University of Aberdeen, Aberdeen, Scotland
,
D Ogston
1   Department of Medicine, University of Aberdeen, Aberdeen, Scotland
,
H. W Fullerton
1   Department of Medicine, University of Aberdeen, Aberdeen, Scotland
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

    Permissions and Reprints

Summary

1. The extent of lysis of artificial thrombi by urokinase is dependent on their fibrin content and on the plasminogen concentration of the plasma from which they are made.

2. The lysis of thrombi in the presence of plasma increases with increasing concentrations of urokinase, but very high urokinase concentrations are inhibitory to thrombolysis.

3. It is postulated that incomplete thrombolysis is due to insufficient plasmin formation within the thrombus, but that plasminogen-containing plasma can diffuse into a thrombus allowing lysis to continue until complete dissolution.

* This study was supported by a grant from the Tobacco Research Council of Great Britain on the recommendation of the British Heart Foundation.


 

  • References

  • 1 Chandler A.B. In: vitro thrombotic coagulation of blood; a method for producing a thrombus. Lab. Invest. 1958; 7: 110
    PubMedGoogle Scholar
  • 2 Poole J.C. A study of artificial thrombi produced by a modification of Chandler's method. Quart. J. exp. Physiol. 1959; 44: 372
    PubMedGoogle Scholar
  • 3 McNicol G.P, Bain W.H, Walker F, Rifkind B.M, Douglas A.S. Thrombolysis studied in an artificial circulation. Lancet 1965; I: 838
    PubMedGoogle Scholar
  • 4 Jacobsen C.D, Chandler A.B. Thrombolysis in vitro. I. Method, comparison of various thrombolytic agents, and factors influencing thrombolysis. Scand. J. clin. Lab. Invest. 17, Suppl. 1965; 84: 209
    PubMedGoogle Scholar
  • 5 Ogston D, Ogston C.M, Fullerton H.W. The plasminogen content of thrombi. Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 15: 220
    PubMedGoogle Scholar
  • 6 Ogston D, Ogston C.M. Factors influencing the lysis of artificial thrombi by urokinase. Scand. J. Haemat. 1967; 4: 61
    PubMedGoogle Scholar
  • 7 Ploug J, Kjeldgaard N.O. Urokinase, an activator of plasminogen from human urine. Biochim. biophys. Acta (Amst.) 1957; 24: 278
    CrossrefPubMedGoogle Scholar
  • 8 Remmert L.F, Cohen P.P. Partial purification and properties of a proteolytic enzyme of human serum. J. biol. Chem. 1949; 181: 431
    PubMedGoogle Scholar
  • 9 Alkjaersig N, Fletcher A.P, Sherry S. The mechanism of clot dissolution by plasmin. J. clin. Invest. 1959; 38: 1086
    CrossrefPubMedGoogle Scholar
  • 10 Ogston C.M, Ogston D. Fibrinogen and plasminogen levels in health and in ischaemic heart disease. J. clin. Path. 1966; 19: 352
    CrossrefPubMedGoogle Scholar
  • 11 Ratnoff O.D, Menzie C. A new method for the determination of fibrinogen in small samples of plasma. J. Lab. clin. Med. 1951; 37: 316
    PubMedGoogle Scholar
  • 12 Hedner U, Nilsson I.M, Robertson B. Determination of plasminogen in clots and thrombi Thrombos. Diathes. haemorrh. (Stuttg.) 1966; 16: 38
    PubMedGoogle Scholar